GLP-1 Injections for Weight Loss

New Service now at OCQ

Introduction

Obesity Clinic Queensland are happy to offer our patients a non-surgical treatment of obesity. Including GLP-1 injections such as: Mounjaro (Tirepatide), Ozempic & Wegovy (Semaglutide), Saxenda (Liraglutide), Trulicity (Dulaglutide).

GLP-1 - Glucagon-Like Peptide-1, GLP-1 is a natural hormone in your body that helps control blood sugar and appetite. Medicines called GLP-1 copy this hormone’s effects—helping people keep their blood sugar in check and making it easier to lose weight by reducing hunger. They’re important because they tackle two of today’s biggest health challenges, diabetes and obesity. GLP-1's support insulin release, reduce glucagon output, slow gastric emptying, aid weight loss and improve metabolic and heart health.

Benefits:

Effective blood sugar control
Significant weight reduction
Improved heart outcomes

Limitations:

Mostly injectable
High cost
GI side effects (nausea, vomiting)

Future Outlook

GLP-1 analogues are transforming diabetes and obesity care. Small molecule GLP-1 agonists promise a major leap forward: oral tablets with strong results in glucose control and weight loss. Early trials show strong results in glucose control and weight loss, with ongoing studies set to confirm safety, efficacy, and long-term benefits. With next-gen combinations, personalised therapies, and a market projected to top $100B by 2030, they’re set to redefine metabolic medicine.